Detalhe da pesquisa
1.
CD4+ T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy.
Immunity
; 57(3): 541-558.e7, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38442708
2.
Distinct immunometabolic signatures in circulating immune cells define disease outcome in acute-on-chronic liver failure.
Hepatology
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38761406
3.
Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization.
Eur Urol
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38670879
4.
PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6high uterine leiomyosarcoma to PD-1 blockade.
Clin Transl Med
; 14(5): e1655, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38711203
5.
Respiratory complex I regulates dendritic cell maturation in explant model of human tumor immune microenvironment.
J Immunother Cancer
; 12(4)2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38604809
6.
PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma.
Nat Commun
; 14(1): 7825, 2023 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030622
7.
The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution.
Cardiovasc Res
; 119(2): 520-535, 2023 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35998078